Low hepatitis C reinfection following direct-acting antiviral therapy among people who inject drugs on opioid agonist therapy MJ Akiyama, D Lipsey, M Heo, L Agyemang, BL Norton, J Hidalgo, K Lora, ... Clinical Infectious Diseases 70 (12), 2695-2702, 2020 | 67 | 2020 |
How medical are states’ medical cannabis policies?: Proposing a standardized scale EL Richard, AD Althouse, JH Arnsten, HW Bulls, D Kansagara, ... International Journal of Drug Policy 94, 103202, 2021 | 26 | 2021 |
A phylogenetic analysis of hepatitis C virus transmission, relapse, and reinfection among people who inject drugs receiving opioid agonist therapy MJ Akiyama, D Lipsey, L Ganova-Raeva, LT Punkova, L Agyemang, ... The Journal of infectious diseases 222 (3), 488-498, 2020 | 17 | 2020 |
Impact of an opt-in eConsult program on primary care demand for specialty visits: stepped-wedge cluster randomized implementation study S Rikin, C Zhang, D Lipsey, J Deluca, EJ Epstein, M Berger, Y Tomer, ... Journal of general internal medicine 35, 832-838, 2020 | 8 | 2020 |